Want to see TSE:BUX full AI Analyst Report?

BioMark Diagnostics (BUX) Revenue

3 Followers

BioMark Diagnostics Revenue

BioMark Diagnostics had a revenue of 7.01K in the quarter ending Jun 30, 2026, with 0.00%. This bring the company's revenue in the last twelve months to 59.79K, Decreased 115.04%. In the fiscal year ending Jun 30, 2026, BioMark Diagnostics had annual revenue of 59.79K with -61.23% growth.

Revenue (ttm)

59.79K

Revenue Growth

-82.05%

P/S Ratio

997.39

Revenue/Employee

C$6,643

Employees

Market Cap

C$59.63M

Revenue Chart

Revenue History

Fiscal End Date	Revenue	Change	Growth
Jun 30, 2026	59.79K	-94.43K	-61.23%
Jun 30, 2025	154.22K	-9.00K	-5.52%
Jun 30, 2024	163.22K	9.73K	+6.34%
Jun 30, 2022	153.49K	―	+∞%
Jun 30, 2021	―	-263.28K	-100.00%
Mar 31, 2020	263.28K	―	+∞%
Mar 31, 2018	―	―	―
Mar 31, 2017	―	―	―